Since November, the stock has appreciated by 36% after the company reported earnings improvement in Q2FY24 on strong demand for its vaccines and general medicine.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
Since November, the stock has appreciated by 36% after the company reported earnings improvement in Q2FY24 on strong demand for its vaccines and general medicine.
| Subscribe To Our Free Newsletter |
